Pioneering Gene Writing™—a new genome engineering technology that writes therapeutic messages into the genome to treat diseases at their source

Developing a machine learning-powered platform can rapidly invent new drugs across a wide range of protein modalities and previously undiscoverable protein therapeutics

Focused on cellular rejuvenation programming to restore cell health and resilience, with the goal of reversing disease to transform medicine

Creating a next-generation enzymatic DNA synthesis platform

Developing first-in-class gene therapies, Anellovector™ therapies, using a novel viral vector platform based on its groundbreaking work on the human commensal virome

Creating endless RNA (eRNA™) —a new class of programmable medicines capable of expressing therapeutic proteins inside the body.

Developing CD8 T cell immune modulators for the treatment of autoimmune diseases